Status:

COMPLETED

Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months

Lead Sponsor:

Society for Applied Studies

Collaborating Sponsors:

World Health Organization

All India Institute of Medical Sciences

Conditions:

Morbidity

Mortality

Eligibility:

All Genders

1-35 years

Phase:

NA

Brief Summary

Children, aged 1 months to 23 months, in the intervention households received zinc, iron and folic acid and those in the control households were administered iron and folic acid (IFA) alone for a peri...

Detailed Description

Objective: Studies in developing countries show substantial reduction in diarrhoea and respiratory morbidity in young children receiving zinc supplementation. The impact of daily zinc supplementation ...

Eligibility Criteria

Inclusion

  • Age 1 months to 23 months
  • Either sex
  • Resident of study area

Exclusion

  • Likely to leave the area during the study period
  • Non consent
  • Temporary exclusion criteria Illness requiring hospitalization Visible severe wasting. Visibly wasted children will be referred to a hospital for treatment. They will be eligible for enrollment only after effective rehabilitation.

Key Trial Info

Start Date :

February 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2003

Estimated Enrollment :

94359 Patients enrolled

Trial Details

Trial ID

NCT00269542

Start Date

February 1 2002

End Date

August 1 2003

Last Update

July 1 2008

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months | DecenTrialz